- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Transthyretin Amyloid Cardiomyopathy in a Young Female ; volume:06 ; number:04 ; year:2021 ; pages:267-274
Indian Journal of Cardiovascular Disease in Women WINCARS ; 06, Heft 04 (2021), 267-274
- Beteiligte Personen und Organisationen
-
Sama, Rajashekhar
- DOI
-
10.1055/s-0042-1742758
- URN
-
urn:nbn:de:101:1-2022040509581011320639
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:20 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Sama, Rajashekhar
Ähnliche Objekte (12)
Diagnosis of Transthyretin Amyloid Cardiomyopathy
Assessment of transthyretin instability in patients with wild-type transthyretin amyloid cardiomyopathy
Transthyretin amyloid cardiomyopathy in women: frequency, characteristics, and diagnostic challenges
Molecular mechanisms and emerging therapies in wild-type transthyretin amyloid cardiomyopathy
Extrapolation of Survival Benefits in Patients with Transthyretin Amyloid Cardiomyopathy Receiving Tafamidis: Analysis of the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial
Clinical characteristics and prognosis of Chinese patients with hereditary transthyretin amyloid cardiomyopathy
Transthyretin amyloid cardiomyopathy in patients with unexplained increased left ventricular wall thickness
Treatment of transthyretin (TTR) amyloid cardiomyopathy with an antisense oligonucleotide inhibitor of TTR synthesis
Annual Cardiovascular-Related Hospitalization Days Avoided with Tafamidis in Patients with Transthyretin Amyloid Cardiomyopathy
Estimating the Prevalence of Transthyretin Amyloid Cardiomyopathy in a Large In-Hospital Database in Japan
Multi-modality artificial intelligence-based transthyretin amyloid cardiomyopathy detection in patients with severe aortic stenosis
RV-PA uncoupling is associated with increased mortality in transthyretin amyloid cardiomyopathy treated with tafamidis
Diagnosis of Transthyretin Amyloid Cardiomyopathy
Assessment of transthyretin instability in patients with wild-type transthyretin amyloid cardiomyopathy
Transthyretin amyloid cardiomyopathy in women: frequency, characteristics, and diagnostic challenges
Molecular mechanisms and emerging therapies in wild-type transthyretin amyloid cardiomyopathy
Extrapolation of Survival Benefits in Patients with Transthyretin Amyloid Cardiomyopathy Receiving Tafamidis: Analysis of the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial
Clinical characteristics and prognosis of Chinese patients with hereditary transthyretin amyloid cardiomyopathy
Transthyretin amyloid cardiomyopathy in patients with unexplained increased left ventricular wall thickness
Treatment of transthyretin (TTR) amyloid cardiomyopathy with an antisense oligonucleotide inhibitor of TTR synthesis
Annual Cardiovascular-Related Hospitalization Days Avoided with Tafamidis in Patients with Transthyretin Amyloid Cardiomyopathy
Estimating the Prevalence of Transthyretin Amyloid Cardiomyopathy in a Large In-Hospital Database in Japan
Multi-modality artificial intelligence-based transthyretin amyloid cardiomyopathy detection in patients with severe aortic stenosis
RV-PA uncoupling is associated with increased mortality in transthyretin amyloid cardiomyopathy treated with tafamidis
Diagnosis of Transthyretin Amyloid Cardiomyopathy
Assessment of transthyretin instability in patients with wild-type transthyretin amyloid cardiomyopathy
Transthyretin amyloid cardiomyopathy in women: frequency, characteristics, and diagnostic challenges
Molecular mechanisms and emerging therapies in wild-type transthyretin amyloid cardiomyopathy
Extrapolation of Survival Benefits in Patients with Transthyretin Amyloid Cardiomyopathy Receiving Tafamidis: Analysis of the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial
Clinical characteristics and prognosis of Chinese patients with hereditary transthyretin amyloid cardiomyopathy
Transthyretin amyloid cardiomyopathy in patients with unexplained increased left ventricular wall thickness
Treatment of transthyretin (TTR) amyloid cardiomyopathy with an antisense oligonucleotide inhibitor of TTR synthesis
Annual Cardiovascular-Related Hospitalization Days Avoided with Tafamidis in Patients with Transthyretin Amyloid Cardiomyopathy
Estimating the Prevalence of Transthyretin Amyloid Cardiomyopathy in a Large In-Hospital Database in Japan
Multi-modality artificial intelligence-based transthyretin amyloid cardiomyopathy detection in patients with severe aortic stenosis